Homoarginine in the cardiovascular system: pathophysiology and recent developments
Upcoming experimental and epidemiological data have identified the endogenous non-proteinogenic amino acid L-homoarginine (L-hArg) not only as a novel biomarker for cardiovascular disease but also as being directly involved in the pathogenesis of cardiac dysfunction. The association of low L-hArg le...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
June 2023
|
| In: |
Fundamental & clinical pharmacology
Year: 2023, Volume: 37, Issue: 3, Pages: 519-5294 |
| ISSN: | 1472-8206 |
| DOI: | 10.1111/fcp.12858 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/fcp.12858 Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1111/fcp.12858 
|
| Author Notes: | Vitali Koch, Leon D. Gruenewald, Tatjana Gruber-Rouh, Katrin Eichler, David M. Leistner, Scherwin Mahmoudi, Christian Booz, Simon Bernatz, Tommaso D'Angelo, Moritz H. Albrecht, Leona S. Alizadeh, Nour-Eldin A. Nour-Eldin, Jan-Erik Scholtz, Ibrahim Yel, Thomas J. Vogl, Winfried März, Stefan E. Hardt, Simon S. Martin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1892806533 | ||
| 003 | DE-627 | ||
| 005 | 20250710225351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240701s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/fcp.12858 |2 doi | |
| 035 | |a (DE-627)1892806533 | ||
| 035 | |a (DE-599)KXP1892806533 | ||
| 035 | |a (OCoLC)1475300938 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Koch, Vitali |d 1985- |e VerfasserIn |0 (DE-588)1072017598 |0 (DE-627)826785611 |0 (DE-576)433486260 |4 aut | |
| 245 | 1 | 0 | |a Homoarginine in the cardiovascular system |b pathophysiology and recent developments |c Vitali Koch, Leon D. Gruenewald, Tatjana Gruber-Rouh, Katrin Eichler, David M. Leistner, Scherwin Mahmoudi, Christian Booz, Simon Bernatz, Tommaso D'Angelo, Moritz H. Albrecht, Leona S. Alizadeh, Nour-Eldin A. Nour-Eldin, Jan-Erik Scholtz, Ibrahim Yel, Thomas J. Vogl, Winfried März, Stefan E. Hardt, Simon S. Martin |
| 264 | 1 | |c June 2023 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Erstmals veröffentlicht: 12. Dezember 2022 | ||
| 500 | |a Gesehen am 01.07.2024 | ||
| 520 | |a Upcoming experimental and epidemiological data have identified the endogenous non-proteinogenic amino acid L-homoarginine (L-hArg) not only as a novel biomarker for cardiovascular disease but also as being directly involved in the pathogenesis of cardiac dysfunction. The association of low L-hArg levels with adverse cardiovascular events and mortality has proposed the idea of nutritional supplementation to rescue pathways inversely associated with cardiovascular health. Subsequent clinical and experimental studies contributed significantly to our knowledge of potential effects on the cardiorenal axis, acting either as a biomarker or a cardiovascular active agent. In this review article, we provide a comprehensive summary of the L-hArg metabolism, pathophysiological aspects, and current developments in the field of experimental and clinical evidence in favor of protective cardiovascular effects. Establishing a reliable biomarker to identify patients at high risk to die of cardiovascular disease represents one of the main goals for tackling this disease and providing individual therapeutic guidance. | ||
| 650 | 4 | |a amino acids | |
| 650 | 4 | |a cardiovascular | |
| 650 | 4 | |a homoarginine | |
| 650 | 4 | |a mortality | |
| 650 | 4 | |a nitric oxide | |
| 700 | 1 | |a Grünewald, Leon David |d 1991- |e VerfasserIn |0 (DE-588)1213268141 |0 (DE-627)1703781732 |4 aut | |
| 700 | 1 | |8 1\p |a Gruber-Rouh, Tatjana |d 1980- |e VerfasserIn |0 (DE-588)142070440 |0 (DE-627)633524263 |0 (DE-576)327740205 |4 aut | |
| 700 | 1 | |8 2\p |a Eichler, Katrin |d 1974- |e VerfasserIn |0 (DE-588)129617229 |0 (DE-627)475207114 |0 (DE-576)297750917 |4 aut | |
| 700 | 1 | |8 3\p |a Leistner, David |d 1981- |e VerfasserIn |0 (DE-588)143548026 |0 (DE-627)647323567 |0 (DE-576)337634033 |4 aut | |
| 700 | 1 | |a Mahmoudi, Scherwin |d 1992- |e VerfasserIn |0 (DE-588)1215512481 |0 (DE-627)1726689840 |4 aut | |
| 700 | 1 | |8 4\p |a Booz, Christian |d 1989- |e VerfasserIn |0 (DE-588)1135674892 |0 (DE-627)89066269X |0 (DE-576)490027261 |4 aut | |
| 700 | 1 | |8 5\p |a Bernatz, Simon |e VerfasserIn |0 (DE-588)121743206X |0 (DE-627)1729838898 |4 aut | |
| 700 | 1 | |a D'Angelo, Tommaso |e VerfasserIn |4 aut | |
| 700 | 1 | |a Albrecht, Moritz H. |e VerfasserIn |4 aut | |
| 700 | 1 | |8 6\p |a Alizadeh, Leona Soraja |d 1993- |e VerfasserIn |0 (DE-588)1209280787 |0 (DE-627)1696926211 |4 aut | |
| 700 | 1 | |8 7\p |a Nour-Eldin, Nour-Eldin Abdelrehim |d 1974- |e VerfasserIn |0 (DE-588)142646369 |0 (DE-627)638054583 |0 (DE-576)332589862 |4 aut | |
| 700 | 1 | |8 8\p |a Scholtz, Jan-Erik |e VerfasserIn |0 (DE-588)1303553678 |0 (DE-627)1860191010 |4 aut | |
| 700 | 1 | |8 9\p |a Yel, Ibrahim |d 1990- |e VerfasserIn |0 (DE-588)1177269295 |0 (DE-627)1048643018 |0 (DE-576)517349884 |4 aut | |
| 700 | 1 | |a Vogl, Thomas J. |d 1958- |e VerfasserIn |0 (DE-588)113728344 |0 (DE-627)503816558 |0 (DE-576)165097159 |4 aut | |
| 700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
| 700 | 1 | |8 10\p |a Hardt, Stefan |e VerfasserIn |0 (DE-588)1028380585 |0 (DE-627)730637611 |0 (DE-576)375919309 |4 aut | |
| 700 | 1 | |a Martin, Simon |d 1987- |e VerfasserIn |0 (DE-588)1072530090 |0 (DE-627)827692706 |0 (DE-576)434008044 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Fundamental & clinical pharmacology |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 37(2023), 3 vom: Juni, Seite 519-5294 |h Online-Ressource |w (DE-627)320452603 |w (DE-600)2006242-4 |w (DE-576)094404062 |x 1472-8206 |7 nnas |a Homoarginine in the cardiovascular system pathophysiology and recent developments |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:3 |g month:06 |g pages:519-5294 |g extent:11 |a Homoarginine in the cardiovascular system pathophysiology and recent developments |
| 856 | 4 | 0 | |u https://doi.org/10.1111/fcp.12858 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/abs/10.1111/fcp.12858 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 4\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 5\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 6\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 7\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 8\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 9\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 10\p |a cgwrk |d 20250701 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20240701 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1027603599 |a März, Winfried |m 1027603599:März, Winfried |d 60000 |d 61400 |e 60000PM1027603599 |e 61400PM1027603599 |k 0/60000/ |k 1/60000/61400/ |p 16 | ||
| 999 | |a KXP-PPN1892806533 |e 454464156X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Erstmals veröffentlicht: 12. Dezember 2022","Gesehen am 01.07.2024"],"name":{"displayForm":["Vitali Koch, Leon D. Gruenewald, Tatjana Gruber-Rouh, Katrin Eichler, David M. Leistner, Scherwin Mahmoudi, Christian Booz, Simon Bernatz, Tommaso D'Angelo, Moritz H. Albrecht, Leona S. Alizadeh, Nour-Eldin A. Nour-Eldin, Jan-Erik Scholtz, Ibrahim Yel, Thomas J. Vogl, Winfried März, Stefan E. Hardt, Simon S. Martin"]},"recId":"1892806533","origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"June 2023"}],"language":["eng"],"person":[{"role":"aut","display":"Koch, Vitali","given":"Vitali","family":"Koch"},{"display":"Grünewald, Leon David","role":"aut","family":"Grünewald","given":"Leon David"},{"family":"Gruber-Rouh","given":"Tatjana","display":"Gruber-Rouh, Tatjana","role":"aut"},{"role":"aut","display":"Eichler, Katrin","given":"Katrin","family":"Eichler"},{"role":"aut","display":"Leistner, David","given":"David","family":"Leistner"},{"family":"Mahmoudi","given":"Scherwin","display":"Mahmoudi, Scherwin","role":"aut"},{"display":"Booz, Christian","role":"aut","family":"Booz","given":"Christian"},{"display":"Bernatz, Simon","role":"aut","family":"Bernatz","given":"Simon"},{"given":"Tommaso","family":"D'Angelo","role":"aut","display":"D'Angelo, Tommaso"},{"display":"Albrecht, Moritz H.","role":"aut","family":"Albrecht","given":"Moritz H."},{"given":"Leona Soraja","family":"Alizadeh","role":"aut","display":"Alizadeh, Leona Soraja"},{"display":"Nour-Eldin, Nour-Eldin Abdelrehim","role":"aut","family":"Nour-Eldin","given":"Nour-Eldin Abdelrehim"},{"role":"aut","display":"Scholtz, Jan-Erik","given":"Jan-Erik","family":"Scholtz"},{"role":"aut","display":"Yel, Ibrahim","given":"Ibrahim","family":"Yel"},{"family":"Vogl","given":"Thomas J.","display":"Vogl, Thomas J.","role":"aut"},{"family":"März","given":"Winfried","display":"März, Winfried","role":"aut"},{"given":"Stefan","family":"Hardt","role":"aut","display":"Hardt, Stefan"},{"given":"Simon","family":"Martin","role":"aut","display":"Martin, Simon"}],"relHost":[{"disp":"Homoarginine in the cardiovascular system pathophysiology and recent developmentsFundamental & clinical pharmacology","note":["Fortsetzung der Druck-Ausgabe"],"title":[{"title_sort":"Fundamental & clinical pharmacology","subtitle":"the international publication of the French Association des Pharmacologistes","title":"Fundamental & clinical pharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"dateIssuedKey":"1987","publisherPlace":"Oxford [u.a.] ; Amsterdam [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","publisher":"Wiley-Blackwell ; Elsevier Science ; Blackwell Science ; Blackwell","dateIssuedDisp":"1987-"}],"titleAlt":[{"title":"Fundamental and clinical pharmacology"}],"recId":"320452603","part":{"text":"37(2023), 3 vom: Juni, Seite 519-5294","pages":"519-5294","issue":"3","extent":"11","year":"2023","volume":"37"},"pubHistory":["1.1987 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["320452603"],"doi":["10.1111/(ISSN)1472-8206"],"issn":["1472-8206"],"zdb":["2006242-4"]}}],"title":[{"title_sort":"Homoarginine in the cardiovascular system","title":"Homoarginine in the cardiovascular system","subtitle":"pathophysiology and recent developments"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1892806533"],"doi":["10.1111/fcp.12858"]},"physDesc":[{"extent":"11 S."}]} | ||
| SRT | |a KOCHVITALIHOMOARGINI2023 | ||